Pàgina inicial > Resultats de la cerca: Martínez, Pablo
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 58 registres trobats en 0.02 segons.
Articles, 52 registres trobats
Contribucions a jornades i congressos, 1 registres trobats
Documents de recerca, 5 registres trobats
Articles 52 registres trobats  1 - 10següentfinal  anar al registre:
1.
11 p, 3.4 MB How are physiological responses to drought modulated by water relations and leaf economics' traits in woody plants? / Da Sois, Luca (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Mencuccini, Maurizio (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Castells, Eva (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Sanchez-Martinez, Pablo (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Martínez Vilalta, Jordi 1975- (Centre de Recerca Ecològica i d'Aplicacions Forestals)
Species' drought resistance is determined by a combination of multiple traits and their plastic response. However, a clear understanding of how these traits are coordinated and modulate plant responses to drought is still lacking. [...]
2024 - 10.1016/j.agwat.2023.108613
Agricultural Water Management, Vol. 291 (February 2024) , art. 108613  
Registre complet - Creative Commons
2.
9 p, 745.8 KB The EMIF-AD Multimodal Biomarker Discovery study : Design, methods and cohort characteristics / Bos, Isabelle (Maastricht University) ; Vos, Stephanie (Maastricht University) ; Vandenberghe, Rik (Katholieke Universiteit Leuven) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Engelborghs, Sebastiaan (University of Antwerp) ; Frisoni, Giovanni (IRCCS Instituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José Luis (Fundació Pasqual Maragall) ; Wallin, Anders (Institute of Neuroscience and Physiology) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Lausanne University Hospital) ; Martinez-Lage, Pablo (Centro de Investigación y Tecnología Agroalimentaria de Aragón) ; Baird, Alison (University of Oxford) ; Dobson, Richard (NIHR University College London Hospitals) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, Kristel (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; Bertram, Lars (University of Oslo) ; Ten Kate, Mara (Amsterdam UMC. University Medical Center) ; Barkhof, Frederik (Amsterdam UMC. University Medical Center) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford) ; Streffer, Johannes (Janssen Pharmaceutical Companies) ; Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ; Universitat Autònoma de Barcelona
There is an urgent need for novel, noninvasive biomarkers to diagnose Alzheimer's disease (AD) in the predementia stages and to predict the rate of decline. Therefore, we set up the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery (EMIF-AD MBD) study. [...]
2018 - 10.1186/s13195-018-0396-5
Alzheimer's research & therapy, Vol. 10 Núm. 1 (june 2018) , p. 64  
Registre complet - Creative Commons
3.
6 p, 731.5 KB A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood : Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort / Stamate, Daniel (University of London) ; Kim, Min (Steno Diabetes Center Copenhagen) ; Proitsi, Petroula (King's College London) ; Westwood, Sarah (University of Oxford) ; Baird, Alison (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, Abdul (King's College London) ; Bos, Isabelle (Amsterdam UMC) ; Vos, Stephanie J.B. (Maastricht University) ; Vandenberghe, Rik (Amsterdam UMC) ; Teunissen, Charlotte E. (Amsterdam UMC. University Medical Center) ; Kate, Mara Ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill (GlaxoSmithKline R&D) ; De Roeck, Ellen (University of Antwerp) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Bordet, Régis (University of Lille) ; Ramit, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Tainta, Mikel (Fundacion CITA-alzheimer Fundazioa) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Molinuevo, José Luis (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at the University of Gothenburg) ; Popp, Julius (Geneva University Hospitals) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Bertram, Lars (University of Oslo) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Streffer, Johannes (University of Antwerp) ; Visser, Pieter J. (Amsterdam UMC) ; Lovestone, Simon (Janssen-Cilag UK Ltd) ; Legido-Quigley, Cristina (King's College London) ; Universitat Autònoma de Barcelona
Machine learning (ML) may harbor the potential to capture the metabolic complexity in Alzheimer Disease (AD). Here we set out to test the performance of metabolites in blood to categorize AD when compared to CSF biomarkers. [...]
2019 - 10.1016/j.trci.2019.11.001
Alzheimer's & dementia, Vol. 5 (2019) , p. 933-938  
Registre complet - Creative Commons
4.
11 p, 783.1 KB Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay / Shi, Liu (University of Oxford) ; Westwood, Sarah (University of Oxford) ; Baird, Alison L. (University of Oxford) ; Winchester, Laura (University of Oxford) ; Dobricic, Valerija (University of Lübeck) ; Kilpert, Fabian (University of Lübeck) ; Hong, Shengjun (University of Lübeck) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Hye, Abdul (King's College London) ; Ashton, Nicholas J. (South London and Maudsley NHS Foundation) ; Morgan, Angharad R. (Cardiff University) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Amsterdam UMC. University Medical Center) ; Buckley, Noel J (University of Oxford) ; Kate, Mara ten (Amsterdam UMC. University Medical Center) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Laboratory for Cognitive Neurology) ; Meersmans, Karen (Laboratory for Cognitive Neurology) ; Engelborghs, Sebastiaan (VUB University Hospital Brussels (UZ Brussel)) ; De Roeck, Ellen E. (Institute Born-Bunge. University of Antwerp) ; Sleegers, Kristel (Center for Molecular Neurology. VIB) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami, Lorena (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (University of Oxford) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (Fundación CITA-Alzhéimer Fundazioa) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter Copenhagen University Hospital ; Teunissen, Charlotte E. (Vrije Universiteit Amsterdam) ; Freund-Levi, Yvonne (King's College London) ; Frölich, Lutz (University of Heidelberg) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Barkhof, Frederik (UCL Institutes of Neurology and Healthcare Engineering) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Baker, Susan (Janssen R&D) ; Morgan, B.Paul (Cardiff University) ; Streffer, Johannes (Janssen R&D. LLC) ; Visser, Pieter Jelle (Karolinska Institutet (Estocolm, Suècia)) ; Bertram, Lars (University of Oslo) ; Lovestone, Simon (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Universitat Autònoma de Barcelona
Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. [...]
2019 - 10.1016/j.jalz.2019.06.4951
Alzheimer's & Dementia, Vol. 15 Núm. 11 (november 2019) , p. 1478-1488  
Registre complet - Creative Commons
5.
9 p, 1012.4 KB Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity : A cross-sectional analysis from the AB255 Study / Pérez-Grijalba, Virginia (Araclon Biotech S.L.) ; Arbizu, Javier (Clínica Universidad de Navarra) ; Romero, Judith (Araclon Biotech S.L.) ; Prieto, Elena (Clínica Universidad de Navarra) ; Pesini, Pedro (Araclon Biotech S.L.) ; Sarasa, Leticia (Araclon Biotech S.L.) ; Guillen, Fernando (Clínica Universidad de Navarra) ; Monleón, Inmaculada (Araclon Biotech S.L.) ; San-José, Itziar (Araclon Biotech S.L.) ; Martínez-Lage, Pablo (Fundación CITA-Alzheimer) ; Munuera, Josep (Institut de Recerca Sant Joan de Déu) ; Hernández, Isabel (Instituto de Salud Carlos III) ; Buendía, Mar (Universitat Internacional de Catalunya) ; Sotolongo-Grau, Oscar (Universitat Internacional de Catalunya) ; Alegret, Montserrat (Instituto de Salud Carlos III) ; Ruiz, Agustín (Instituto de Salud Carlos III) ; Tárraga, Lluís (Instituto de Salud Carlos III) ; Boada, Mercè (Instituto de Salud Carlos III) ; Sarasa, Manuel (Araclon Biotech S.L.) ; Goñi Imízcoz, Miguel (Hospital Divino Vallés (Burgos)) ; Pujadas, Francesc ; Villarejo, Alberto ; Frank, Ana ; Peña-Casanova, Jordi ; Fernández, Manuel ; Piñol, Gerard ; Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ; Gil, Pedro ; Pascual, Luis F. ; Aguilar Barberà, Miquel ; Frisoni, Giovanni B. ; Matias-Guiu, Jorge ; Andreasen, Niels ; Antúnez, Carmen ; Universitat Autònoma de Barcelona
To facilitate population screening and clinical trials of disease-modifying therapies for Alzheimer's disease, supportive biomarker information is necessary. This study was aimed to investigate the association of plasma amyloid-beta (Aβ) levels with the presence of pathological accumulation of Aβ in the brain measured by amyloid-PET. [...]
2019 - 10.1186/s13195-019-0549-1
Alzheimer's research & therapy, Vol. 11 Núm. 1 (january 2019) , p. 96  
Registre complet - Creative Commons
6.
22 p, 986.7 KB Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort / Kim, Min (Steno Diabetes Center Copenhagen) ; Snowden, Stuart (University of Cambridge) ; Suvitaival, Tommi (Steno Diabetes Center Copenhagen) ; Ali, Ashfaq (Steno Diabetes Center Copenhagen) ; Merkler, David J. (University of South Florida) ; Ahmad, Tahmina (King's College London) ; Westwood, Sarah (University of Oxford) ; Baird, Alison (University of Oxford) ; Proitsi, Petroula (King's College London) ; Nevado-Holgado, Alejo (University of Oxford) ; Hye, Abdul (Steno Diabetes Center Copenhagen) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie (Maastricht University) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Teunissen, Charlotte (Amsterdam Neuroscience) ; ten Kate, Mara (Amsterdam Neuroscience) ; Scheltens, Philip (Amsterdam UMC. University Medical Center) ; Gabel, Silvy (KU Leuven) ; Meersmans, Karen (KU Leuven) ; Blin, Olivier ; Richardson, Jill (GlaxoSmithKline R&D) ; De Roeck, Ellen (University of Antwerp) ; Sleegers, Kristel (VIB) ; Bordet, Régis (University of Lille) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (John Radcliffe Hospital (Oxford, Regne Unit)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Frisoni, Giovanni B. (University of Geneva) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Wallin, Anders (University of Gothenburg) ; Popp, Julius (Geneva University Hospitals) ; Martinez-Lage, Pablo (CITA-Alzheimer Foundation) ; Bertram, Lars (University of Lübeck) ; Barkhof, Frederik (Amsterdam Neuroscience) ; Ashton, Nicholas J (University of Gothenburg) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Streffer, Johannes (Janssen Pharmaceutical Companies) ; Visser, Pieter J. (Amsterdam Neuroscience) ; Lovestone, Simon (University of Oxford) ; Legido-Quigley, Cristina (Steno Diabetes Center Copenhagen) ; Universitat Autònoma de Barcelona
A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of peripheral small molecule biomarkers. Given that brain pathology precedes clinical symptom onset, we set out to test whether metabolites in blood associated with pathology as indexed by cerebrospinal fluid (CSF) AD biomarkers. [...]
2019 - 10.1016/j.jalz.2019.03.004
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 817-827  
Registre complet - Creative Commons
7.
12 p, 1.1 MB Inflammatory biomarkers in Alzheimer's disease plasma / Morgan, Angharad R. (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, Cardiff University (Regne Unit)) ; Touchard, Samuel (Systems Immunity Research Institute and UK Dementia Research Institute Cardiff, School of Medicine, Cardiff University (Regne Unit)) ; Leckey, Claire A. (Cardiff University (Regne Unit)) ; O'Hagan, Caroline (Cardiff University (Regne Unit)) ; Nevado-Holgado, Alejo (University of Oxford (Regne Unit)) ; Barkhof, Frederik (University College London) ; Bertram, Lars (Max Planck Institute for Molecular Genetics (Alemanya)) ; Blin, Olivier (Aix-Marseille University (França)) ; Bos, Isabelle (Maastricht University (Països Baixos)) ; Dobricic, Valerija (University of Lübeck (Alemanya)) ; Engelborghs, Sebastiaan (Institute Born-Bunge (Bèlgica)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli (Brescia, Itàlia)) ; Froelich, Lutz (University of Heidelberg (Alemanya)) ; Gabel, Silvy (Laboratory for Cognitive Neurology (Leuven, Bèlgica)) ; Johannsen, Peter (Karolinska Institutet (Stockholm, Sweden)) ; Kettunen, Petronella (University of Gothenburg (Gothenburg, Suècia)) ; Kłoszewska, Iwona (Medical University of Lodz (Lodz, Poland)) ; Legido-Quigley, Cristina (Imperial College London) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Martinez-Lage, Pablo (Fundación CITA-Alzheimer Fundazioa (San Sebastian, Spain)) ; Mecocci, Patrizia (University of Perugia (Itàlia)) ; Meersmans, Karen (Laboratory for Cognitive Neurology (Bèlgica)) ; Molinuevo, José Luis (Universitat Pompeu Fabra) ; Peyratout, Gwendoline (Lausanne University Hospital (Suïssa)) ; Popp, Julius (Hopitaux Universitaires Geneve and Universite de Geneve (Suïssa)) ; Richardson, Jill (GlaxoSmithKline R&D (Regne Unit)) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Scheltens, Philip (Vrije Universiteit (Països Baixos)) ; Streffer, Johannes (University of Antwerp) ; Soininen, Hikka (University of Eastern Finland) ; Tainta, Mikel (Fundación CITA Alzheimer (Sant Sebastià, País Basc)) ; Teunissen, Charlotte E (University Hospitals Leuven (Bèlgica)) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Vandenberghe, Rik (Amsterdam University Medical Centers (Països Baixos)) ; Visser, Pieter Jelle (Maastricht University (Països Baixos)) ; Vos, Stephanie (Maastricht University (Països Baixos)) ; Wahlund, Lars Olof (Karolinska Institutet (Estocolm, Suècia)) ; Wallin, Anders (University of Gothenburg Sahlgrenska Academy) ; Westwood, Sarah (University of Oxford (Regne Unit)) ; Zetterberg, Henrik (UK Dementia Research Institute (Londres, Regne Unit)) ; Lovestone, Simon (University of Oxford (Regne Unit)) ; Morgan, B. Paul (Cardiff University (Regne Unit)) ; Bullmore, Edward (University of Cambridge (Regne Unit)) ; Bhatti, Junaid (University of Cambridge (Regne Unit)) ; Chamberlain, Samuel J. (University of Cambridge (Regne Unit)) ; Correia, Marta Morgado (University of Cambridge (Regne Unit)) ; Crofts, Anna L. (Université de Sherbrooke (Canadà)) ; Dickinson, Amber (Addenbroke's Hospital (Cambridge, Regne Unit)) ; Foster, Andy C. (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ; Kitzbichler, Manfred G. (University of Cambridge (Regne Unit)) ; Knight, Clare (Cambridgeshire and Peterborough NHS Foundation Trust (Regne Unit)) ; Lynall, Mary-Ellen (University of Cambridge (Regne Unit)) ; Maurice, Christina (University of Cambridge (Regne Unit)) ; O'Donnell, Ciara M. (University College London (Regne Unit)) ; Pointon, Linda J. (University of Cambridge (Regne Unit)) ; St George Hyslop, Peter (University of Cambridge (Regne Unit)) ; Turner, Lorinda (University of Cambridge (Regne Unit)) ; Vertes, Petra E. (University of Cambridge (Regne Unit)) ; Widmer, Barry (University of Cambridge (Regne Unit)) ; Williams, Guy (University of Cambridge (Regne Unit)) ; Cavanagh, Jonathan T. O. (Karolinska Institutet (Estocolm, Suècia)) ; Deith, Catherine (Southern General Hospital Glasgow (Escòcia)) ; Farmer, Scott (Bio Med Sciences Inc.(Galveston, Estats Units)) ; McClean, John (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ; McColl, Alison (College of Medical, Veterinary & Life Sciences (Glasgow, Escòcia)) ; McPherson, Andrew (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Scouller, Paul (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Sutherland, Murray (NHS Greater Glasgow and Clyde (Glasgow, Escòcia)) ; Boddeke, Erik W.G.M. (Københavns UniversitetThe institution (Copenhaguen, Dinamarca)) ; Khan, Shahid (GlaxoSmithKline plc. (Regne Unit)) ; Murphy, Philip Stephen (GlaxoSmithKline plc. (Regne Unit)) ; Parker, Christine A. (Wellcome Trust (Londres, Regne Unit)) ; Patel, Jai (GlaxoSmithKline plc. (Regne Unit)) ; Jones, Declan (Janssen Pharmaceuticals (Titusville, Estats Units)) ; de Boer, Peter (Janssen Research & Development (Beerse, Bèlgica)) ; Kemp, John A. (KU Leuven- University Hospital Leuven (Bèlgica)) ; Drevets, Wayne Curtis (Janssen Research & Development (Beerse, Bèlgica)) ; Nye, Jeffrey S. (Janssen Research & Development (Beerse, Bèlgica)) ; Wittenberg, Gayle M. (Janssen Research & Development (Beerse, Bèlgica)) ; Isaac, John T.R. (Johnson & Johnson (Estats Units)) ; Bhattacharya, Anindya (Janssen Research & Development (Beerse, Bèlgica)) ; Carruthers, Niicholas L. (Janssen Research & Development (Beerse, Bèlgica)) ; Kolb, Hartmuth Christian (Janssen Research & Development (Beerse, Bèlgica)) ; Pariante, Carmine M. (King's College London (Regne Unit)) ; Turkheimer, Federico (King's College London (Regne Unit)) ; Barker, Gareth John (King's College London (Regne Unit)) ; Byrom, Heidi (King's College London (Regne Unit)) ; Cash, Diana (King's College London (Regne Unit)) ; Cattaneo, Annamaria (King's College London (Regne Unit)) ; Gee, Anthony (King's College London (Regne Unit)) ; Hastings, Caitlín N.M. (King's College London (Regne Unit)) ; Mariani, Nicole (King's College London (Regne Unit)) ; McLaughlin, Anna Patricia (King's College London (Regne Unit)) ; Mondelli, Valeria (King's College London (Regne Unit)) ; Nettis, Maria Antonietta (King's College London (Regne Unit)) ; Nikkheslat, Naghmeh (King's College London (Regne Unit)) ; Randall, Karen (King's College London (Regne Unit)) ; Sheridan, Hannah C. (King's College London (Regne Unit)) ; Simmons, Camilla (King's College London (Regne Unit)) ; Singh, Nisha (King's College London (Regne Unit)) ; Van Loo, Victoria (King's College London (Regne Unit)) ; Vicente-Rodríguez, Marta (King's College London (Regne Unit)) ; Wood, Tobias (King's College London (Regne Unit)) ; Worrell, Courtney (King's College London (Regne Unit)) ; Zajkowska, Zuzanna (King's College London (Regne Unit)) ; Plath, Niels (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Egebjerg, Jan (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Eriksson, Hans (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Gastambide, Francois (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Adams, Karen Husted (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Jeggo, Ross D. (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Thomsen, Christian (Aalborg Universitetshospital (Aalborg, Dinamarca)) ; Pederson, Jan Torleif (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Campbell, Brian M. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; Möller, Thomas (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; Nelson, Bob (H. Lundbeck A/S (Copenhagen, Dinamarca)) ; Zorn, Stevin H. (Lundbeck Research USA Inc. (Deerfield, Estats Units)) ; O'Connor, Jason (University of Texas Hlth Sci Ctr San Antonio(Estats Units)) ; Attenburrow, Mary Jane (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Baird, Alison (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Benjamin, Jithen (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Clare, Stuart (John Radcliffe Hosp, Oxford Ctr Funct MRI Brain (Oxford, Anglaterra)) ; Cowen, Philip (University of Oxford (Anglaterra)) ; Huang, I-Shuo Wade (Kennedy Inst Rheumatol (Oxford, Anglaterra)) ; Hurley, Samuel A. (University of Wisconsin-Madison (Madison, Estats Units)) ; Jones, Helen (Warneford Hosp, NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Mada, Francisca (Neurosciences & Neurology) ; Nevado-Holgado, Alejo (University of Oxford (Anglaterra)) ; Oladejo, Akitayo (Metropolitan Hospital Center (New York, Estats Units)) ; Ribe, Elena (King's College London (Londres, Anglaterra)) ; Smith, Katy (Warneford Hospital. NIHR Oxford Cognit Hlth Clin Res Facil (Oxford, Anglaterra)) ; Vyas, Anviti (University of Oxford (Oxford, Anglaterra)) ; Hughes, Zoe (Praxis Precision Medicines (Cambridge, Regne Unit)) ; Balice-Gordon, Rita (Sanofi S.A. (Gentilly, França)) ; Duerr, James M. (Pfizer Inc.(New York, Estats Units)) ; Piro, Justin R. (Pfizer Inc.(New York, Estats Units)) ; Sporn, Jonathan (Gilgamesh Pharmaceut (New York, Estats Units)) ; Perry, V. Hugh (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Cleal, Madeleine (University of Portsmouth (Anglaterra)) ; Fryatt, Gemma (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Gomez-Nicola, Diego (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Mancuso, Renzo (University of Southampton (Anglaterra)) ; Reynolds, Richard (University of Southampton. Ctr Biol Sci (Hants, Anglaterra)) ; Harrison, Neil (University fo Sussex (Brighton, Anglaterra)) ; Cercignani, Mara (University fo Sussex (Brighton, Anglaterra)) ; Clarke, Charlotte L. (University of Sussex (Brighton, Regne Unit)) ; Hoskins, Elizabeth (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ; Kohn, Charmaine (Sussex Partnership NHS Foundation Trust (Worthing, Regne Unit)) ; Murray, Rosemary (Addenbrooke's Hospital (Cambridge, Regne Unit)) ; Wilcock, Lauren (Sussex Partnership NHS Fdn Trust (Hove, Anglaterra)) ; Wlazly, Dominika (Brighton and Sussex University Hospitals NHS Trust (Sussex, Anglaterra)) ; Mount, Howard T.J. (University of Toronto (Toronto, Canadà)) ; Universitat Autònoma de Barcelona
Plasma biomarkers for Alzheimer's disease (AD) diagnosis/stratification are a "Holy Grail" of AD research and intensively sought; however, there are no well-established plasma markers. A hypothesis-led plasma biomarker search was conducted in the context of international multicenter studies. [...]
2019 - 10.1016/j.jalz.2019.03.007
Alzheimer's & Dementia, Vol. 15 Núm. 6 (june 2019) , p. 776-787  
Registre complet - Creative Commons
8.
51 p, 1.5 MB Shaping the niche of Taxus baccata, a modelling exercise using biologically meaningful information / Sanchez-Martinez, Pablo (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Marcer, Arnald (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Mayol, Maria (Centre de Recerca Ecològica i d'Aplicacions Forestals) ; Riba Rovira, Miquel (Centre de Recerca Ecològica i d'Aplicacions Forestals)
Widely used Correlative Species Distribution Models (C-SDMs) usually make some simplifying assumptions, often failing to consider important ecological and evolutionary attributes potentially hindering the characterization of the species niche. [...]
2021 - 10.1016/j.foreco.2021.119688
Forest ecology and management, Vol. 501 (Dec. 2021) , art. 119688  
Registre complet - Creative Commons
9.
13 p, 162.5 KB Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort / Westwood, Sarah (University of Oxford) ; Baird, Alison L (University of Oxford) ; Anand, Sneha N. (University of Oxford) ; Nevado-Holgado, Alejo (University of Oxford) ; Kormilitzin, Andrey (University of Oxford) ; Shi, Liu (University of Oxford) ; Hye, Abdul (King's College London) ; Ashton, Nicholas J (University of Gothenburg) ; Morgan, Angharad R. (Cardiff University) ; Bos, Isabelle (Maastricht University) ; Vos, Stephanie J.B. (Maastricht University) ; Baker, Susan (Janssen R and D) ; Buckley, Noel J (University of Oxford) ; Ten Kate, Mara (Vrije Universiteit University Medical Center) ; Scheltens, Philip (Vrije Universiteit University Medical Center) ; Teunissen, Charlotte E. (Vrije Universiteit University Medical Center) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Gabel, Silvy (Ku Leuven) ; Meersmans, Karen (Ku Leuven) ; Engelborghs, Sebastiaan (Vrije Universiteit Brussel (VUB)) ; De Roeck, Ellen E. (Vrije Universiteit Brussel (VUB)) ; Sleegers, Kristel (Center for Molecular Neurology) ; Frisoni, Giovanni B. (Irccs Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R and D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami, Lorena (Universitat Pompeu Fabra) ; Wallin, Anders (Sahlgrenska Academy at University of Gothenburg) ; Kettunen, Petronella (Sahlgrenska Academy at University of Gothenburg) ; Tsolaki, Magda (AHEPA University Hospital (Grècia)) ; Verhey, Frans (Maastricht University) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Geneva University Hospitals) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (Geneva University Hospitals) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Johannsen, Peter (Copenhagen University Hospital) ; Freund-Levi, Yvonne (Karolinska Institutet (Estocolm, Suècia)) ; Frölich, Lutz (University of Heidelberg) ; Dobricic, Valerija (University of Lübeck) ; Legido-Quigley, Cristina (Steno Diabetes Center) ; Bertram, Lars (University of Oslo) ; Barkhof, Frederik (Ucl Institutes of Neurology and Healthcare Engineering) ; Zetterberg, Henrik (Ucl Institute of Neurology) ; Morgan, B.Paul (Cardiff University) ; Streffer, Johannes (Janssen R and D. Llc) ; Visser, Pieter Jelle (Vu University Medical Center) ; Lovestone, Simon (Janssen R and D) ; Universitat Autònoma de Barcelona
We have previously investigated, discovered, and replicated plasma protein biomarkers for use to triage potential trials participants for PET or cerebrospinal fluid measures of Alzheimer's disease (AD) pathology. [...]
2020 - 10.3233/JAD-190434
Journal of Alzheimer's disease, Vol. 74 Núm. 1 (2020) , p. 213-225  
Registre complet - Creative Commons
10.
12 p, 1.3 MB Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset / Hong, Shengjun (University of Lübeck) ; Prokopenko, Dmitry (Massachusetts General Hospital) ; Dobricic, Valerija (University of Lübeck) ; Kilpert, Fabian (University of Lübeck) ; Bos, Isabelle (Vrije Universiteit Amsterdam) ; Vos, Stephanie J.B. (Maastricht University) ; Tijms, Betty M (Vrije Universiteit Amsterdam) ; Andreasson, Ulf (Sahlgrenska University Hospital (Suècia)) ; Blennow, Kaj (Sahlgrenska University Hospital (Suècia)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Cleynen, Isabelle (KU Leuven) ; Gabel, Silvy (KU Leuven) ; Schaeverbeke, Jolien (KU Leuven) ; Scheltens, Philip (Vrije Universiteit Amsterdam) ; Teunissen, Charlotte E. (Vrije Universiteit) ; Niemantsverdriet, Ellis (University of Antwerp) ; Engelborghs, Sebastiaan (UZ Brussel and Vrije Universiteit Brussel (VUB)) ; Frisoni, Giovanni B. (IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli) ; Blin, Olivier (Aix-Marseille Université) ; Richardson, Jill C. (GlaxoSmithKline R&D) ; Bordet, Régis (University of Lille) ; Molinuevo, José Luis (Hospital Clínic i Provincial de Barcelona) ; Rami Gonzalez, Lorena (Hospital Clínic i Provincial de Barcelona) ; Kettunen, Petronella (University of Oxford) ; Wallin, Anders (University of Gothenburg) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Sala, Isabel (Institut d'Investigació Biomèdica Sant Pau) ; Popp, Julius (Lausanne University Hospital) ; Peyratout, Gwendoline (Lausanne University Hospital) ; Martinez-Lage, Pablo (CITA-Alzheimer Foundation) ; Tainta, Mikel (CITA-Alzheimer Foundation) ; Dobson, Richard J.B. (University College London) ; Legido-Quigley, Cristina (King's College London) ; Sleegers, Kristel (University of Antwerp) ; Van Broeckhoven, Christine (University of Antwerp) ; ten Kate, Mara (Amsterdam Neuroscience) ; Barkhof, Frederik (University College London) ; Zetterberg, Henrik (UK Dementia Research Institute) ; Lovestone, Simon (University of Oxford) ; Streffer, Johannes (UCB Biopharma SPRL) ; Wittig, Michael (Christian-Albrechts-University of Kiel) ; Franke, Andre (Christian-Albrechts-University of Kiel) ; Tanzi, Rudolph E. (Massachusetts General Hospital) ; Visser, Pieter Jelle (Vrije Universiteit Amsterdam) ; Bertram, Lars (University of Oslo) ; Universitat Autònoma de Barcelona
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder and the most common form of dementia in the elderly. Susceptibility to AD is considerably determined by genetic factors which hitherto were primarily identified using case-control designs. [...]
2020 - 10.1038/s41398-020-01074-z
Translational psychiatry, Vol. 10 Núm. 1 (december 2020) , p. 403  
Registre complet - Creative Commons

Articles : 52 registres trobats   1 - 10següentfinal  anar al registre:
Contribucions a jornades i congressos 1 registres trobats  
1.
12 p, 1.5 MB 60 anys després de la Cova del Calvari (Amposta, Montsià). Revisió en curs i aportació de noves dades analítiques al Campaniforme del nord-est de la Península Ibèrica / Soriano, Eni (Universitat de Lleida. Departament d'Història) ; Martínez, Pablo (Universitat de Barcelona. Departament de Prehistòria, Història Antiga i Arqueologia) ; Labaune, Matthieu (Université de Bourgogne) ; Cattin, Florence (Université de Bourgogne) ; Oliart Caravatti, Camila (Universitat Autònoma de Barcelona)
La Cova del Calvari (Amposta, Montsià, Tarragona) constitueix un jaciment funerari únic corresponent al grup Campaniforme, format per "contexts tancats" relativament intactes (cinc tombes individuals i una col·lectiva). [...]
Calvary Cave (Amposta, Tarragona province, Spain) is a unique burial site corresponding to Bell Beaker, consisting of comparatively intact "closed finds" (five individual graves and one collective tomb). [...]
Barcelona: Generalitat de Catalunya. Departament de Cultura, 2016
Actes de les I Jornades d'Arqueologia de les Terres de l'Ebre 2016. (Volum I), pag 104-115  
Registre complet -

Documents de recerca 5 registres trobats  
1.
1 p, 947.3 KB Nanobiosensor per a la detecció ambiental dels diferents serotips del virus de la grip / Félez Martínez, Pablo ; Farrés, Jaume, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Facultat de Biociències
2015
Grau en Biotecnologia [815]  
Registre complet - Creative Commons
2.
171 p, 5.8 MB The therapeutic potential of mesenchymal stem cells & FGF8 in chronic demyelinating diseases / Cruz Martinez, Pablo ; Martínez Pérez, Salvador, dir. ; Jones Barberá, Jonathan Richard, dir. ; Claro Izaguirre, Enrique, dir. (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Universitat Autònoma de Barcelona. Institut de Neurociències
Diferentes investigadores han demostrado el potencial terapéutico de las células madre mesenquimales (MSCs) en diversos trastornos neurodegenerativos, incluyendo las enfermedades desmielinizantes. Sin embargo, este efecto se observó por lo general únicamente a nivel local, en el área donde se inyectaban las células madre. [...]
Several researchers have demonstrated the therapeutic potential of mesenchymal stem cells (MSCs) in various neurodegenerative disorders, including demyelinating diseases. However, this effect was generally observed only locally, in the surrounding area where the MSCs were transplanted. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2015  
Registre complet - Creative Commons
3.
105 p, 1.6 MB Cáncer de pulmón de célula no pequeña ALK positivo. Prevalencia y características. La inmunohistoquímica como método diagnóstico / Martínez Rodríguez, Pablo ; Felip, Enriqueta, dir. ; Suriñach Caralt, Josep María, dir. ; Selva O'Callaghan, Albert, tut. ; Universitat Autònoma de Barcelona. Departament de Medicina
Antecedentes: las translocaciones de ALK (anaplastic lymphoma kinase) representan una nueva diana terapéutica en un subgrupo de pacientes con cáncer de pulmón de célula no pequeña (CPCNP). En el presente estudio pretendemos analizar la prevalencia y características de los pacientes ALK positivo en una muestra de pacientes con CPCNP y valorar la utilidad de la inmunohistoquímica (IHC) como método diagnóstico. [...]
Background: ALK rearrangement represents a novel molecular target in a subset of non small cell lung cancers (NSCLC). Our aim is to explore fluorescence in situ hybridization (FISH) and immunohistochemistry (IHC) as diagnostic methods, prevalence and clinical outcomes of ALK rearrangement patients in a selected population of NSCLC. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2015  
Registre complet - Creative Commons
4.
238 p, 3.5 MB Diseño, fabricación y optimización de detectores con multiplicación (LGAD) para experimentos de física de altas energías / Fernández Martínez, Pablo ; Flores Gual, David, dir. ; Hidalgo Villena, Salvador, dir. ; Universitat Autònoma de Barcelona. Departament d'Enginyeria Electrònica
Cuando los dispositivos semiconductores, especialmente los basados en control por puerta MOS, se someten a una dosis elevada de radiación, sus características eléctricas se deterioran rápidamente. [...]
Semiconductor devices, especially those based on MOS gate control, subjected to a high dose of radiation, suffer from a fast deterioration of their electrical characteristics. Furthermore, the miniaturization and the thinning of the different layers used in device fabrication, enhance the radiation sensitivity. [...]
[Barcelona] : Universitat Autònoma de Barcelona, 2014  
Registre complet - Creative Commons
5.
9 p, 84.3 KB ALK rearrangement in a selected population of advanced non small cell lung cancer patients. FISH and inmunohistochemistry diagnostic methods, prevalence and clinical outcomes / Martínez Rodríguez, Pablo ; Felip, Enriqueta ; Suriñach, Josep María ; Universitat Autònoma de Barcelona. Departament de Medicina ; Universitat Autònoma de Barcelona. Facultat de Medicina
Anaplastic lymphoma kinase (ALK) rearrangements represents a new driver oncogenic event in non-small cell lung cancer (NSCLC). ALK positive patients account for a 1-7% of NSCLC patients. The objective of this study is to know the prevalence and clinical characteristics of ALK positive patients in a cohort of NSCLC patients and to compare inmunohistochemistry with D5F3 monoclonal antibody with gold standard method fluorescence in situ hybridation.
Les translocacions del gen de la quinasa del linfoma anaplàssic (ALK) suposen una nova alteració oncogénica en el càncer de pulmó de cèl·lula no petita (CPNM). Els pacients ALK positius suposen un 1-7% dels pacients amb CPNM. [...]
2012  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
7 Martinez, P.
12 Martinez, P. Fernandez
1 Martinez, P.A.
3 Martinez, Pablo
6 Martinez, Paula
1 Martinez, Pedro Antonio
5 Martinez, Pilar
7 Martínez, P.
8 Martínez, Paola
1 Martínez, Pascual
1 Martínez, Patricia
6 Martínez, Paula
2 Martínez, Paz
1 Martínez, Paz,
1 Martínez, Pedro Rafael
1 Martínez, Pelayo
1 Martínez, Philippe
5 Martínez, Pilar
5 Martínez, Pitu
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem